By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Health Canada 

A.L. 0904A

Ottawa    K1A 0K9  Canada
Phone: 613-957-2991 Fax: 613-941-5366



Company News
Eli Lilly Canada Inc. (LLY) Release: Health Canada's Approval Of Taltz (Ixekizumab) Brings Targeted Therapy To Canadians Living With Moderate-To-Severe Plaque Psoriasis 6/21/2016 11:18:20 AM
Pfizer Canada Release: Health Canada Approves INFLECTRA (Biosimilar Infliximab) For Three Additional Indications: Crohn's Disease, Fistulising Crohn's Disease And Ulcerative Colitis 6/15/2016 11:12:11 AM
Bristol-Myers Squibb Canada (BMY) Release: Health Canada Approves DAKLINZA (Daclatasvir) For Difficult-To-Treat Hepatitis C Patient Populations 5/24/2016 6:23:19 AM
Cerus (CERS) Release: Health Canada Approves INTERCEPT Blood System For Plasma 5/23/2016 10:24:28 AM
Health Canada Authorizes ProMetic Life Sci (PFSCF.PK) To Proceed With Its PBI-4050 Clinical Trial In Patients With Cystic Fibrosis 5/18/2016 7:03:24 AM
Health Canada To Propose Regulatory Change To Enable Consideration Of Applications Under The Special Access Programme To Facilitate Treatment Of Chronic Relapsing Opioid Dependence 5/16/2016 6:55:39 AM
STAAR Surgical (STAA) Announces Approval By Health Canada Of Its EVO Visian ICL For Surgeons And Their Patients In Canada 5/13/2016 6:41:27 AM
Pfizer Canada Release: Health Canada Approves New First-Line Treatment For Women Living With Metastatic Breast Cancer 5/10/2016 6:34:23 AM
AstraZeneca Canada (AZN) Release: Health Canada Approves LYNPARZA For The Treatment Of Ovarian Cancer In Patients With BRCA-Mutations 5/3/2016 6:19:13 AM
Aralez Receives Health Canada Approval For Blexten 4/25/2016 6:01:44 AM